815 (Atomoxetine 18 mg)
Pill imprint 815 has been identified as Atomoxetine hydrochloride 18 mg.
Atomoxetine is used in the treatment of adhd; social anxiety disorder; fibromyalgia; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Atomoxetine 18 mg is not a controlled substance under the Controlled Substance Act (CSA).
Atomoxetine hydrochloride
- Imprint:
- 815
- Strength:
- 18 mg
- Color:
- Yellow & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 47335-0815
- Inactive Ingredients:
- corn starch
silicon dioxide
gelatin
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
More about atomoxetine
Consumer resources
- Other brands: Strattera
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
